Please login to the form below

Not currently logged in


This page shows the latest protein news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

An intravenous version of the CAR therapy – which targets a protein called mesothelin found on the surface of malignant cells – is also in preclinical development for other solid tumours.

Latest news

More from news
Approximately 3 fully matching, plus 648 partially matching documents found.

Latest Intelligence

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    At the time there was a strong scientific belief in the central dogma, that is ‘one gene codes for one protein’.

  • ‘How is your day?’ ‘How is your day?’

    ‘ How is your day?’. The initiative that shows how plasma protein therapies improve lives. ... How is Your Day' is an initiative of the Plasma Protein Therapeutics Association.

  • 30 Women Leaders in UK Healthcare

    Dr Marshall is a world-leading expert in G-Protein-Coupled-Receptor (GPCR) biology and drug discovery.

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    Dr Sarah Teichmann is a world-leading researcher in genomics and molecular biology, working in numerous collaborative efforts to unlock the mysteries and complexities of gene expression and proteins interactions in

  • No incentive for a cure No incentive for a cure

    to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.

More from intelligence
Approximately 2 fully matching, plus 58 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    society. “ We look at the manufacturing challenges we are facing for emerging healthcare products, such as stratified protein therapeutics and personalised cell therapies.

  • Alzheimer's and Brain Awareness Month

    The symptoms of AD are believed to be caused by an atypical build-up of proteins within the brain in the forms of ‘ plaques’ and ‘ tangles’, which impairs connections between neurons ... It is particularly challenging to tackle AD, as is it still

  • Introduction to the manufacturing of biologics

    However, the broad definition of a biologic is they are created by either a microorganism or a mammalian cell, and are large, complex molecules; the majority of which are proteins

  • Forecasting in Forgotten Markets

    From a scientific perspective, the jury is still out on the root cause of these conditions and whether the current hypothesis around the involvement of Amyloid and Tau proteins in different

  • Flarebio Biotech LLC

    Our main business includes recombinant proteins and antibodies (CusAb), ELISA kits (CUSABIO), raw materials for diagnostic reagents (CUSAg), food safety testing products (WHISERKON).

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....